Yingjun Shi
Impact in
-
- Immunotherapy and Immune Responses
- interferon and immune responses
-
- Mesenchymal stem cell research
Papers in
- Co-authors
- Xiaolong Liu (11 shared papers)Youshi Zheng (6 shared papers)Bixing Zhao (7 shared papers)Yingchao Wang (7 shared papers)Jingfeng Liu (5 shared papers)Naishun Liao (6 shared papers)Yongyi Zeng (2 shared papers)Cuilin Zhang (4 shared papers)
- Journals
- Small (2 papers)Stem Cell Research & Therapy (2 papers)EMBO Molecular Medicine (1 paper)Signal Transduction and Targeted Therapy (1 paper)ACS Synthetic Biology (1 paper)
- Partner nations
- China
In The Last Decade
Yingjun Shi
14 papers receiving 396 citations
Peers
Comparison fields: 5 of 70
- Immunology 115
- Genetics 46
- Aging 7
- Cancer Research 49
- Oncology 66
Countries citing papers authored by Yingjun Shi
This map shows the geographic impact of Yingjun Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingjun Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingjun Shi more than expected).
Fields of papers citing papers by Yingjun Shi
This network shows the impact of papers produced by Yingjun Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingjun Shi. The network helps show where Yingjun Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Yingjun Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 105 | |
| 2 | 2022 | 68 | |
| 3 | 2021 | 64 | |
| 4 | 2019 | 40 | |
| 5 | 2020 | 35 | |
| 6 | 2020 | 35 | |
| 7 | 2019 | 33 | |
| 8 | 2021 | 14 | |
| 9 | 2023 | 6 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 2 | |
| 12 | 2025 | 2 | |
| 13 | 2024 | 1 | |
| 14 | 2024 | 1 |
About Yingjun Shi
Yingjun Shi is a scholar working on Oncology, Genetics, Cancer Research, Hepatology and Immunology, having authored 14 papers that have together received 408 indexed citations. Recurring topics across this work include CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers), Mesenchymal stem cell research (3 papers), CRISPR and Genetic Engineering (2 papers), MicroRNA in disease regulation (2 papers), Cancer, Lipids, and Metabolism (1 paper), Cancer Research and Treatments (1 paper) and Cancer Cells and Metastasis (1 paper). The work is most often cited by research in Immunology (115 citations), Genetics (46 citations), Aging (7 citations), Cancer Research (49 citations) and Oncology (66 citations). Yingjun Shi has collaborated with scholars based in China. Frequent co-authors include Xiaolong Liu, Youshi Zheng, Bixing Zhao, Yingchao Wang, Jingfeng Liu, Naishun Liao, Yongyi Zeng, Cuilin Zhang, Zhaowei Chen and Da Zhang. Their work appears in journals such as Small, Stem Cell Research & Therapy, EMBO Molecular Medicine, Signal Transduction and Targeted Therapy and ACS Synthetic Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.